Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Tathmini ya Teknolojia ya Afya× | Uchanganuzi wa Gharama na Ufanisi katika Tathmini ya Teknolojia ya Afya× | |
|---|---|---|
| Nyanja | Usimamizi wa Huduma za Afya | Usimamizi wa Huduma za Afya |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 1980 | 1996 |
| Mwanzilishi≠ | International HTA organizations, National Institutes of Health | Diane Meade Drummond, Michael Gold |
| Aina≠ | Structured assessment methodology | Economic evaluation methodology |
| Chanzo asilia≠ | Goodman, C. S. (2004). HTA 101: Introduction to Health Technology Assessment (Version 1.0). National Library of Medicine, National Institutes of Health. link ↗ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 |
| Majina mbadala | HTA, Technology Assessment Healthcare | CEA, Cost-Effectiveness Analysis Healthcare |
| Zinazohusiana | 5 | 5 |
| Muhtasari≠ | Health Technology Assessment (HTA) is a structured, multidisciplinary approach to evaluating the clinical, economic, and societal effects of healthcare technologies (devices, drugs, procedures, systems). HTA synthesizes evidence from clinical trials, observational studies, and economic analyses to support decision-makers in adoption and reimbursement determinations. | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. |
| ScholarGateSeti ya data ↗ |
|
|